SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ☑ 1934 For the quarterly period ended January 31, 2023 Or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ☐ 1934 For the transition period from to Commission file number 001-11504 CHAMPIONS ONCOLOGY, INC. (Exact name of registrant as defined in its charter) Delaware 52-1401755 (State or other jurisdiction of (I.R ...